JetEquities

Enochian Biosciences Acquires an Exclusive License for a Novel H

Long
NASDAQ:ENOB   Enochian Biosciences, Inc
ENOB: Enochian Biosciences, Inc.
2020-02-03 07:30:10
Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.